Abcam (ABC)

Sector:

Pharma and Biotech

Index:

FTSE AIM 50

1,110.00p
   
  • Change Today:
      11.00p
  • 52 Week High: 1,750.00
  • 52 Week Low: 1,049.00
  • Currency: UK Pounds
  • Shares Issued: 228.94m
  • Volume: 118,505
  • Market Cap: £2,541.24m
  • RiskGrade: 134

Regulatory News

Update on 2021 General Meeting Resolution Vote 02-Dec-2021 07:00 RNS
Total Voting Rights 30-Nov-2021 15:25 RNS
Issue of Equity and Replacement PDMR Notification 12-Nov-2021 17:28 RNS
Total Voting Rights 12-Nov-2021 16:17 RNS
Issue of Equity and Replacement PDMR Notification 12-Nov-2021 12:34 RNS
Issue of Equity and PDMR Notification 10-Nov-2021 16:56 RNS
Vesting of All Employee Share Scheme 05-Nov-2021 15:19 RNS
Total Voting Rights 29-Oct-2021 14:42 RNS
Completion of BioVision Acquisition 27-Oct-2021 07:00 RNS
Holding(s) in Company 12-Oct-2021 16:46 RNS
Block listing Interim Review 11-Oct-2021 16:21 RNS
Holding(s) in Company 06-Oct-2021 10:35 RNS
Director/PDMR Shareholding 24-Sep-2021 16:03 RNS
Interim results for the 6 and 12 month periods 13-Sep-2021 12:00 RNS
Total Voting Rights 01-Sep-2021 16:02 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Abcam Market Data

Currency UK Pounds
Share Price 1,110.00p
Change Today 11.00p
% Change 1.00 %
52 Week High 1,750.00
52 Week Low 1,049.00
Volume 118,505
Shares Issued 228.94m
Market Cap £2,541.24m
RiskGrade 134

Abcam Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
92.4% below the market average92.4% below the market average92.4% below the market average92.4% below the market average92.4% below the market average
92.73% below the sector average92.73% below the sector average92.73% below the sector average92.73% below the sector average92.73% below the sector average
Price Trend
67.24% below the market average67.24% below the market average67.24% below the market average67.24% below the market average67.24% below the market average
3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average3.23% below the sector average
Income
97.43% below the market average97.43% below the market average97.43% below the market average97.43% below the market average97.43% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average
Growth
96.75% above the market average96.75% above the market average96.75% above the market average96.75% above the market average96.75% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 4
Buy 1
Neutral 8
Sell 0
Strong Sell 0
Total 13
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Abcam Dividends

  Latest Previous
  Interim Final
Ex-Div 19-Mar-20 07-Nov-19
Paid 17-Apr-20 29-Nov-19
Amount 3.55p 8.58p

Trades for 17-May-2022

Time Volume / Share Price
16:35 43,344 @ 1,110.00p
16:29 33 @ 1,109.00p
16:29 2 @ 1,109.00p
16:29 8 @ 1,109.00p
16:29 10 @ 1,111.00p

Abcam Key Personnel

CEO Alan Thomas Hirzel
CFO Michael Baldock

Top of Page